Research Paper Volume 14, Issue 2 pp 826—844

A new signature based on alternative polyadenylation for prognostic prediction and therapeutic responses in low-grade glioma


Figure 3. Development and validation of a four-APA-based prognostic signature. The risk score distribution, gene expression, and LGG patients’ survival status in the training (AC), test (DF), and whole sets (GI) based on the signature.